SCHEMBL4774078

SCHEMBL4774078

CCn1cnc2c(=O)nc(Cc3cccc(C(F)(F)F)c3)n(-c3ccc(F)cc3)c21

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
BRD9 Q9H8M2 1/20 0.38
CCR1 P32246 3/20 0.38
P2RX3 P56373 1/20 0.38
CDK1 P06493 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CCR2 P41597 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
PRKCA P17252 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4517305 0.86 MAOB (0.41) MEN1KMT2ABRD9CCR1P2RX3
SCHEMBL4768907 0.79 SMN1; SMN2 (0.34) MEN1KMT2ABRD9CDK1KDM4E
SCHEMBL4521578 0.77 TP53 (0.42) MEN1KMT2ACCR1P2RX3CDK1
SCHEMBL4772467 0.77 MAT2A (0.40) MEN1KMT2ABRD9ALDH1A1SMN1; SMN2
SCHEMBL4284448 0.74 NPC1 (0.34) CDK1ALDH1A1SMN1; SMN2
SCHEMBL4357095 0.73 MAT2A (0.38) MEN1KMT2ACDK1KDM4EALDH1A1
SCHEMBL4793975 0.73 KMT2A (0.45) MEN1KMT2ACDK1SMN1; SMN2MAOA
SCHEMBL4769839 0.73 NPC1 (0.33) ALDH1A1SMN1; SMN2
SCHEMBL5768791 0.72 DDR1 (0.37) ALDH1A1MAOB
SCHEMBL5768045 0.70 PLA2G7 (0.36) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed